Livzon Pharmaceutical Group Inc
000513
Company Profile
Business description
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. It is a pharmaceutical group covering pharmaceutical R&D, production and commercialization. The company's products include chemical drugs, biological drugs, and traditional Chinese medicine. It distributes its products within domestic markets and to overseas markets. The company operates in a single operating segment in the PRC, i.e. the manufacture of pharmaceuticals.
Contact
38 Chuangye North Road
Headquarters Building, Jinwan District
Guangdong Province
Zhuhai519090
CHNT: +86 7568135888
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
8,878
Stocks News & Analysis
stocks
This ASX supermarkets business is now underperforming its largest competitor
Competition restrains long-term margins.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,903.30 | 31.20 | 0.35% |
| CAC 40 | 8,025.74 | 49.62 | 0.62% |
| DAX 40 | 24,238.64 | 247.37 | 1.03% |
| Dow JONES (US) | 48,941.90 | 557.37 | -1.13% |
| FTSE 100 | 10,265.23 | 98.70 | -0.95% |
| HKSE | 25,898.61 | 197.27 | -0.76% |
| NASDAQ | 25,067.80 | 46.64 | -0.19% |
| Nikkei 225 | 59,513.12 | 228.20 | 0.38% |
| NZX 50 Index | 13,035.70 | 61.98 | -0.47% |
| S&P 500 | 7,200.75 | 29.37 | -0.41% |
| S&P/ASX 200 | 8,680.50 | 38.80 | 0.45% |
| SSE Composite Index | 4,112.16 | 4.65 | 0.11% |